5-Bromo-4-methyl-2-phenylpyridine

Catalog No.: 
ACKGSX751
CAS No.: 
31686-64-3
Molecular Formula: 
C12H10BrN
Molecular Weight: 
248.12
5-Bromo-4-methyl-2-phenylpyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$164.00InquiryInquiry
250mg95%$245.00InquiryInquiry
1g95%$612.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-4-methyl-2-phenylpyridine
IUPAC Name5-bromo-4-methyl-2-phenylpyridine
MDL No.MFCD23713141
Molecular FormulaC12H10BrN
Molecular Weight248.12
SMILESCC1=CC(C2=CC=CC=C2)=NC=C1Br
InChI KeyNUXIJRHGJXCNDZ-UHFFFAOYSA-N
Synonym5-bromo-4-methyl-2-phenylPyridine;Pyridine, 5-bromo-4-methyl-2-phenyl-
CAS No.31686-64-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACKGSX751 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQBXZ071 route compound structure diagram
    ACQBXZ0713430-26-0In Stock
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6In Stock
  4. Then
  5. ACKGSX751 route product structure diagram
    ACKGSX75131686-64-3
Inquiry

2. ACKGSX751 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6In Stock
  4. Then
  5. ACKGSX751 route product structure diagram
    ACKGSX75131686-64-3
Inquiry

3. ACKGSX751 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVYUA568 route compound structure diagram
    ACVYUA568778611-64-6In Stock
  4. Then
  5. ACKGSX751 route product structure diagram
    ACKGSX75131686-64-3
Inquiry

Comments (0)